Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update
$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024
Uptick in patient recruitment for Mino-Lok® Phase 3 trial
Halo-Lido Phase 2b trial nearing completion
CRANFORD,...
Ohio State University Completes Study on Pressure Bioscience (PBIO) and Protein Drinks.
Pressure BioSciences' Ultra Shear Technology Positioned for Critical Enabling Role in Global $41 Billion (2027) Plant Protein Beverage Market.
Recent Study Published by The Ohio...
Interview: Ric Schumacher CEO, Pressure Bioscience (PBIO)
Our favorite interview to date, and there have been dozens. Filmed November of 2021, and the story has gotten to much better since.
https://vimeo.com/652106617
$PBIO,...
Latest article
Report III: A Deeper Dive Into the Nutriband’s (NTRB) $200 Million Revenue Estimate.
Look at the Basic Math and Decide for Yourself.
Click Here to Open
News coverage and reporting client. See report for full disclosure and disclaimer details.
Standard...
Report II: Updating Coverage on Nutriband (NTRB) $7.77.
Hmm. The number 777 is commonly interpreted as a sign of spiritual alignment, good fortune. Let's hope these revenue forecasts are on the money!...
Pan Global Resources (PGZ) Investor Presentation.
Pan Global Resources (PGZ, PGZFF) a Proven Ground Exploration company, will doing a non-deal roadshow in the Palm Beach Area tonight. We'll attend and...
